Multivessel versus Culprit-Only Revascularization Strategies in Cardiac Arrest Survivors

Wei-Ting Chen1, Min-Shan Tsai1, Chien-Hua Huang1

  • 1Department of Emergency Medicine, National Taiwan University Medical College and Hospital, Taipei.

Insights

Multivessel revascularization reduced in-hospital mortality in cardiac arrest survivors with multivessel coronary artery disease compared to culprit-only revascularization. This benefit was particularly evident in patients with prolonged resuscitation times.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • The optimal revascularization strategy for cardiac arrest survivors with multivessel coronary artery disease is not well-defined.
  • Current guidelines do not definitively favor multivessel over culprit-only revascularization in this patient population.

Purpose of the Study:

  • To retrospectively evaluate the association between multivessel revascularization and culprit-only revascularization with in-hospital mortality in cardiac arrest survivors presenting with multivessel coronary artery disease.

Main Methods:

  • Retrospective analysis of 273 cardiac arrest survivors undergoing emergent coronary angiography within 24 hours.
  • 90 patients with multivessel coronary artery disease were analyzed, divided into multivessel (n=45) and culprit-only (n=45) revascularization groups.
  • In-hospital mortality and neurological outcomes were compared between the two groups.

Main Results:

  • Multivessel revascularization was associated with significantly lower in-hospital mortality (37.8% vs. 55.6%; adjusted HR=0.47, p=0.035).
  • The survival benefit of multivessel revascularization was more pronounced in patients with prolonged cardiopulmonary resuscitation (>10 min) (adjusted HR=0.27, p=0.03).
  • No significant difference in neurological outcomes was observed between the groups (adjusted OR=1.22, p=0.753).

Conclusions:

  • Multivessel revascularization appears to be associated with reduced in-hospital mortality in cardiac arrest survivors with multivessel coronary artery disease.
  • The findings suggest a potential benefit of a more comprehensive revascularization approach in select cardiac arrest survivors.
  • Further prospective studies are warranted due to the observational nature and small sample size of this study.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
97
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
51
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35